搜尋
Avalo Therapeutics Inc
AVTX添加自選
18.151USD
+0.392+2.20%
交易中 （美東）報價延遲15分鐘
447.21M總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
5.13%
T. Rowe Price Investment Management, Inc.
3.51%
BVF Partners L.P.
3.27%
Nantahala Capital Management, LLC
2.98%
OrbiMed Advisors, LLC
2.87%
其他
82.23%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
5.13%
T. Rowe Price Investment Management, Inc.
3.51%
BVF Partners L.P.
3.27%
Nantahala Capital Management, LLC
2.98%
OrbiMed Advisors, LLC
2.87%
其他
82.23%
股東類型
持股股東
佔比
Hedge Fund
25.28%
Investment Advisor
17.19%
Investment Advisor/Hedge Fund
7.29%
Private Equity
3.96%
Research Firm
3.14%
Venture Capital
2.39%
Individual Investor
1.74%
Sovereign Wealth Fund
0.79%
Pension Fund
0.05%
其他
38.18%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
136
24.87M
60.06%
+6.95M
2025Q4
92
15.54M
49.88%
+220.47K
2025Q3
100
15.32M
50.75%
+6.89M
2025Q2
75
7.84M
82.00%
-412.02K
2025Q1
82
8.26M
75.30%
+101.94K
2024Q4
82
7.57M
64.56%
+817.70K
2024Q3
76
6.75M
29.89%
+3.87M
2024Q2
97
946.19K
12.26%
+816.58K
2024Q1
119
129.62K
6.10%
+66.52K
2023Q4
128
65.08K
5.28%
+59.48K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
2.13M
9.33%
+1.91M
+864.97%
Feb 27, 2026
BVF Partners L.P.
1.36M
5.95%
+1.00
+0.00%
Dec 31, 2025
Nantahala Capital Management, LLC
1.24M
5.42%
--
--
Dec 31, 2025
OrbiMed Advisors, LLC
1.19M
5.21%
-162.00K
-12.01%
Dec 31, 2025
UBS Financial Services, Inc.
477.82K
2.1%
+432.61K
+956.93%
Dec 31, 2025
Affinity Asset Advisors LLC
1.05M
4.61%
--
--
Jan 22, 2026
Millennium Management LLC
934.43K
4.1%
+28.63K
+3.16%
Feb 17, 2026
Caligan Partners, LP
881.53K
3.87%
+48.20K
+5.78%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Health Innovation Active ETF
0.07%
iShares Micro-Cap ETF
0.03%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Health Innovation Active ETF
佔比0.07%
iShares Micro-Cap ETF
佔比0.03%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%